Prohibiting Adversarial Patents Act of 2026

Referred to the House Committee on the Judiciary.

• Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Judiciary Committee
  House of Representatives

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• BIOTECHNOLOGY INNOVATION ORGANIZATION
  for BIOTECHNOLOGY INNOVATION ORGANIZATION · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
  for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• GSK (FKA GLAXOSMITHKLINE INC.)
  for GSK (FKA GLAXOSMITHKLINE INC.) · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• FRANKLIN SQUARE GROUP, LLC
  for ITC MODERNIZATION ALLIANCE · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• FRANKLIN SQUARE GROUP, LLC
  for HIGH TECH INVENTORS ALLIANCE · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• DAVID W JONES
  for HIGH TECH INVENTORS ALLIANCE · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  11 filings
• SENATE
  11 filings
• Patent & Trademark Office (PTO)
  9 filings
• Commerce, Dept of (DOC)
  6 filings
• Health & Human Services, Dept of (HHS)
  6 filings
• Office of Management & Budget (OMB)
  6 filings
• Centers For Medicare and Medicaid Services (CMS)
  5 filings
• Treasury, Dept of
  4 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.